CANTATA EvaluatorSM for CUTR

Methodology  

New CE: Go  
Company Information
Symbol: CUTR
Company: Cutera, Inc.
Company Description: Cutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; Juliet, a laser system for vaginal health; and Secret RF, a fractional radio frequency microneedling device for skin revitalization. In addition, the company offers GenesisPlus, CoolGlide, myQ, enlighten SR, and truSculpt iD products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills and marketing brochures through the Internet. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners, as well as for physicians offering aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.
Stock is Optionable: Yes
SEC Filings Edgar Online
General Due Diligence and Earnings Date Info: Due Diligence
Exchange: NASDAQ
CANTATA Evaluation for 11/21/2019
CE Zone
Time- liness CET CEF CE* Industry Industry
Rank
Industry
Score
4-3 0/2 6.52 / 7 6.18 / 11 12.7 /18 Medical Appliances & Equipment 195 / 215 53 / 100
*Excluding Timeliness points
Timeliness
Item Data Points Maximum
Possible
1
Currently listed on CwH, FB, DB, HTF or SQZ watchlists
0 1
2
Broke out in last 5 days and within 5% of BoP
0 1
 
Total Timeliness Points
0 2
CANTATA Evaluation Technical (CET)
Item Data Points Maximum
Possible
1 Price relative to 50 and 200 day moving averages; 50 day relative to 200 day moving average
Last Close: $ 37.5
50 dma $ 31.17
200 dma $ 23.33
2.80 3
2 Relative Strength Rank
RS 98
0.99 1
3 Rank in Industry
Rank in Industry 2
# of stocks in Industry 61
0.98 1
4 Price relative to 52 week high
% off 52 week high 3.55 %
1.00 1
5 Up/Down Ratio
Up/Down Ratio: 1.5
0.75 1
  Miscellaneous Technical Data (no points assigned)
Beta 0.880
PE (vs. S&P 500) -9999999999.990 (-496770988.57 x)
5yr PE low - high -9999999999.990 - 95.770
n/a n/a
  Total Technical Points (CET) 6.52 7
CANTATA Evaluation Fundamentals (CEF)
1 Quarter over Quarter Earnings Growth
06/30/19 0.041 vs. -0.115 [ 135.65 %]
03/31/19 -0.586 vs. -0.150 [ -290.67 %]
12/31/18 -1.887 vs. 2.051 [ -192.00 %]
09/30/18 -0.063 vs. 0.419 [ -115.04 %]
0.60 1
2 Positive Quarterly Earnings 1.00 1
3 Quarterly Earnings Growth Acceleration 0.40 1
4 Year over Year Earnings Growth Rates
12/31/18 -2.234 [ -188 %]    
12/31/17 2.532 [ 1254 %]    
12/31/16 0.187 [ 159 %]    
12/31/15 -0.318 [ 57 %]    
12/31/14 -0.744 [ 0 %]    
0.60 1
5 Quarter over Quarter Sales Growth Rates
06/30/19 47.800 vs. 42.600 [ 12.21 %]
03/31/19 36.000 vs. 34.100 [ 5.57 %]
12/31/18 45.500 vs. 47.600 [ -4.41 %]
09/30/18 40.600 vs. 38.200 [ 6.28 %]
0.38 1
6 Quarterly Sales Growth Rate Acceleration 0.70 1
7 Forward Earnings Growth Rates
Est. EPS growth current Fiscal Yr to next 34.500 %
Est. EPS Growth Next Fiscal Yr to Following 63.500 %
1.00 1
8 Institutional Ownership
Number of Institutional Owners 165.000
Net shares purchased MRQ ('000) -17.000
Institutional Ownership Details  
0.50 1
9 Return on Equity (ROE)
ROE - TTM -69.91 %
0.00 1
10 Cash Flow:
Cash from operations MRQ 4.000
Earnings TTM -35.158656
Cash from operations TTM 2.900
Cash flow above/below earnings TTM 1.08
1.00 1
11 Net Margins
12/31/18 -18.900%
12/31/17 19.800%
12/31/16 2.200%
0.00 1
  Miscelleneous Fundamental Data (no points assigned)
Financial Overview
Long term debt to equity 0.000 %  
Current Fiscal Year End 12/31/19  
Yearly Sales ('000) 12/31/18 162.700
      12/31/17 151.500
      12/31/16 118.100
      12/31/15 94.800
      12/31/14 78.100
n/a n/a
  Total Fundamental Points (CEF) 6.18 11
  Total CANTATA Evaluation Points 12.70 18